Authors: Larner, J

Citation: J. Larner, D-chiro-inositol in insulin action and insulin resistance - Old-fashioned biochemistry still at work, IUBMB LIFE, 51(3), 2001, pp. 139-148

Authors: Kendall, E Buys, N Larner, J

Citation: E. Kendall et al., Community-based service delivery in rehabilitation: The promise and the paradox, DISABIL REH, 22(10), 2000, pp. 435-445

Authors: Fonteles, MC Almeida, MQ Larner, J

Citation: Mc. Fonteles et al., Antihyperglycemic effects of 3-O-methyl-D-chiro-inositol and D-chiro-inositol associated with manganese in streptozotocin diabetic rats, HORMONE MET, 32(4), 2000, pp. 129-132

Authors: Larner, J Huang, LC

Citation: J. Larner et Lc. Huang, Identification of a novel inositol glycan signaling pathway with significant therapeutic relevance to insulin resistance: an insulin signaling model using both tyrosine kinase and G-proteins, DIABET REV, 7(3), 1999, pp. 217-231

Authors: Huang, LC Heimark, D Linko, J Nolan, R Larner, J

Citation: Lc. Huang et al., A model phosphatase 2C -> phosphatase 1 activation cascade via dual control of inhibitor-1 (INH-1) and DARPP-32 dephosphorylation by two inositol glycan putative insulin mediators from beef liver, BIOC BIOP R, 255(1), 1999, pp. 150-156

Authors: Larner, J Jane, J Laws, E Packer, R Myers, C Shaffrey, M

Citation: J. Larner et al., A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme, AM J CL ONC, 21(6), 1998, pp. 579-583